KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Sarepta Therapeutics (SRPT) over the last 13 years, with Q3 2025 value amounting to $159.9 million.

  • Sarepta Therapeutics' Other Working Capital Changes rose 10047.02% to $159.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 4780.85%. This contributed to the annual value of -$32.2 million for FY2024, which is 6296.13% up from last year.
  • Sarepta Therapeutics' Other Working Capital Changes amounted to $159.9 million in Q3 2025, which was up 10047.02% from $25.6 million recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Other Working Capital Changes ranged from a high of $159.9 million in Q3 2025 and a low of -$85.4 million during Q1 2025
  • Moreover, its 5-year median value for Other Working Capital Changes was -$22.5 million (2022), whereas its average is -$11.1 million.
  • Per our database at Business Quant, Sarepta Therapeutics' Other Working Capital Changes crashed by 453814.43% in 2022 and then soared by 45456.77% in 2024.
  • Over the past 5 years, Sarepta Therapeutics' Other Working Capital Changes (Quarter) stood at -$29.0 million in 2021, then rose by 22.56% to -$22.5 million in 2022, then grew by 10.74% to -$20.1 million in 2023, then tumbled by 256.31% to -$71.5 million in 2024, then skyrocketed by 323.5% to $159.9 million in 2025.
  • Its last three reported values are $159.9 million in Q3 2025, $25.6 million for Q2 2025, and -$85.4 million during Q1 2025.